JAGUAR HEALTH, INC. Interest Expense
JAGUAR HEALTH, INC. (JAGX) reported Interest Expense of $161.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-19
- JAGUAR HEALTH, INC. interest expense for the quarter ending 2026-06-30 was $161.00K.
- JAGUAR HEALTH, INC. interest expense for the quarter ending 2026-03-31 was $699.00K.
- JAGUAR HEALTH, INC. interest expense for the quarter ending 2025-12-31 was $132.00K.
- JAGUAR HEALTH, INC. interest expense for the quarter ending 2025-09-30 was $6.00K.
- JAGUAR HEALTH, INC. interest expense for fiscal 2025 was $67.00K, a 71.00% decline from fiscal 2024.
- JAGUAR HEALTH, INC. interest expense for fiscal 2024 was $231.00K, a 96.38% decline from fiscal 2023.
- JAGUAR HEALTH, INC. interest expense for fiscal 2023 was $6.38M, a 49.84% decline from fiscal 2022.
- JAGUAR HEALTH, INC. interest expense for fiscal 2022 was $12.72M, a 51.09% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $161.00K 10-Q · filed 2026-08-19 | $860.00K 10-Q · filed 2026-08-19 | $992.00K derived: sum of 3 quarters · filed 2026-08-19 | $998.00K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $699.00K 10-Q · filed 2026-05-20 | $831.00K derived: sum of 2 quarters · filed 2026-05-20 | $837.00K derived: sum of 3 quarters · filed 2026-05-20 | $822.00K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $138.00K derived: sum of 2 quarters · filed 2026-04-07 | $123.00K derived: sum of 3 quarters · filed 2026-08-19 | $67.00K 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-14 | -$9.00K derived: sum of 2 quarters · filed 2026-08-19 | -$65.00K 10-Q · filed 2025-11-14 | -$175.00K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | -$15.00K 10-Q · filed 2026-08-19 | -$71.00K 10-Q · filed 2026-08-19 | -$181.00K derived: sum of 3 quarters · filed 2026-08-19 | -$343.00K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | -$56.00K 10-Q · filed 2026-05-20 | -$166.00K derived: sum of 2 quarters · filed 2026-05-20 | -$328.00K derived: sum of 3 quarters · filed 2026-05-20 | -$436.00K derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | -$272.00K derived: sum of 2 quarters · filed 2026-04-07 | -$380.00K derived: sum of 3 quarters · filed 2026-04-07 | $231.00K 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | -$162.00K 10-Q · filed 2025-11-14 | -$270.00K derived: sum of 2 quarters · filed 2025-11-14 | $341.00K 10-Q · filed 2025-11-14 | $589.00K derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | -$108.00K 10-Q · filed 2025-08-14 | $503.00K 10-Q · filed 2025-08-14 | $751.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.25M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $611.00K 10-Q · filed 2025-05-15 | $859.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.36M derived: sum of 3 quarters · filed 2025-05-15 | $4.81M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $748.00K derived: sum of 2 quarters · filed 2025-03-31 | $4.20M derived: sum of 3 quarters · filed 2025-03-31 | $6.38M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $500.00K 10-Q · filed 2024-11-13 | $3.95M derived: sum of 2 quarters · filed 2024-11-13 | $6.13M 10-Q · filed 2024-11-13 | $8.77M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $3.45M 10-Q · filed 2024-08-13 | $5.63M 10-Q · filed 2024-08-13 | $8.27M derived: sum of 3 quarters · filed 2024-08-13 | $11.00M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $2.18M 10-Q · filed 2024-05-14 | $4.82M derived: sum of 2 quarters · filed 2024-05-14 | $7.55M derived: sum of 3 quarters · filed 2024-05-14 | $10.08M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.37M derived: sum of 2 quarters · filed 2024-04-01 | $7.90M derived: sum of 3 quarters · filed 2024-04-01 | $12.72M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $2.73M 10-Q · filed 2023-11-14 | $5.27M derived: sum of 2 quarters · filed 2023-11-14 | $10.09M 10-Q · filed 2023-11-14 | $11.89M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $2.54M 10-Q · filed 2023-08-14 | $7.36M 10-Q · filed 2023-08-14 | $9.16M derived: sum of 3 quarters · filed 2023-08-14 | $11.24M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $4.19M 10-Q · filed 2023-05-15 | $6.63M derived: sum of 2 quarters · filed 2023-05-15 | $8.71M derived: sum of 3 quarters · filed 2023-05-15 | $10.71M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $4.51M derived: sum of 2 quarters · filed 2023-03-24 | $6.52M derived: sum of 3 quarters · filed 2023-03-24 | $8.42M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $2.08M 10-Q · filed 2022-11-14 | $4.09M derived: sum of 2 quarters · filed 2022-11-14 | $5.99M 10-Q · filed 2022-11-14 | $7.52M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $2.01M 10-Q · filed 2022-08-22 | $3.91M 10-Q · filed 2022-08-22 | $5.44M derived: sum of 3 quarters · filed 2022-08-22 | $6.02M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | $1.90M 10-Q · filed 2022-05-10 | $3.43M derived: sum of 2 quarters · filed 2022-05-10 | $4.01M derived: sum of 3 quarters · filed 2022-05-10 | $4.49M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.11M derived: sum of 2 quarters · filed 2022-03-11 | $2.59M derived: sum of 3 quarters · filed 2022-03-11 | $2.79M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $581.00K 10-Q · filed 2021-11-17 | $1.06M derived: sum of 2 quarters · filed 2021-11-17 | $1.26M 10-Q · filed 2021-11-17 | $1.43M derived: sum of 4 quarters · filed 2021-11-17 | ||||
| 2020-06-30 | $479.00K 10-Q · filed 2021-08-13 | $678.00K 10-Q · filed 2021-08-13 | $852.00K derived: sum of 3 quarters · filed 2021-08-13 | $2.21M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $199.00K 10-Q · filed 2021-05-17 | $373.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.73M derived: sum of 3 quarters · filed 2021-05-17 | $5.38M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.53M derived: sum of 2 quarters · filed 2021-03-31 | $5.18M derived: sum of 3 quarters · filed 2021-03-31 | $5.73M 10-K · filed 2021-03-31 | $5.73M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | $1.35M 10-Q · filed 2020-11-16 | $1.35M 10-Q · filed 2019-11-14 | $5.01M derived: sum of 2 quarters · filed 2020-11-16 | $5.56M 10-Q · filed 2020-11-16 | $5.56M 10-Q · filed 2019-11-14 | $6.00M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $3.66M 10-Q · filed 2020-08-13 | $3.66M 10-Q · filed 2019-08-14 | $4.20M 10-Q · filed 2020-08-13 | $4.20M 10-Q · filed 2019-08-14 | $4.65M derived: sum of 3 quarters · filed 2020-08-13 | $5.52M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $547.00K 10-Q · filed 2020-05-15 | $547.13K 10-Q · filed 2019-05-21 | $989.82K derived: sum of 2 quarters · filed 2020-05-15 | $1.86M derived: sum of 3 quarters · filed 2020-05-15 | $2.57M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $442.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $1.31M derived: sum of 2 quarters · filed 2020-04-03 | $2.03M derived: sum of 3 quarters · filed 2020-04-03 | $2.63M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $872.04K 10-Q · filed 2019-11-14 | $1.58M derived: sum of 2 quarters · filed 2019-11-14 | $2.19M 10-Q · filed 2019-11-14 | $2.59M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $711.80K 10-Q · filed 2019-08-14 | $1.31M 10-Q · filed 2019-08-14 | $1.72M derived: sum of 3 quarters · filed 2019-08-14 | $2.19M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $602.02K 10-Q · filed 2019-05-21 | $1.01M derived: sum of 2 quarters · filed 2019-05-21 | $1.48M derived: sum of 3 quarters · filed 2019-05-21 | $1.63M derived: sum of 4 quarters · filed 2019-05-21 | ||||
| 2017-12-31 | $408.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $873.43K derived: sum of 2 quarters · filed 2019-04-10 | $1.03M derived: sum of 3 quarters · filed 2019-04-10 | $1.21M 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | $464.68K 10-Q · filed 2018-11-19 | $620.81K derived: sum of 2 quarters · filed 2018-11-19 | $800.88K 10-Q · filed 2018-11-19 | $1.01M derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | $156.13K 10-Q · filed 2018-08-13 | $336.20K 10-Q · filed 2018-08-13 | $547.57K derived: sum of 3 quarters · filed 2018-08-13 | $782.76K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $180.07K 10-Q · filed 2018-05-15 | $391.44K derived: sum of 2 quarters · filed 2018-05-15 | $626.63K derived: sum of 3 quarters · filed 2018-05-15 | $881.38K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $211.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | $446.56K derived: sum of 2 quarters · filed 2018-04-09 | $701.31K derived: sum of 3 quarters · filed 2018-04-09 | $985.55K 10-K · filed 2018-04-09 | ||||
| 2016-09-30 | $235.19K 10-Q · filed 2017-11-20 | $489.95K derived: sum of 2 quarters · filed 2017-11-20 | $774.18K 10-Q · filed 2017-11-20 | $1.06M derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | $254.76K 10-Q · filed 2017-08-09 | $538.99K 10-Q · filed 2017-08-09 | $823.04K derived: sum of 3 quarters · filed 2017-08-09 | $986.64K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $284.24K 10-Q/A · filed 2017-06-23 | $568.28K derived: sum of 2 quarters · filed 2017-06-23 | $731.88K derived: sum of 3 quarters · filed 2017-06-23 | $2.67M derived: sum of 4 quarters · filed 2017-06-23 | ||||
| 2015-12-31 | $284.05K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $447.64K derived: sum of 2 quarters · filed 2017-02-15 | $2.38M derived: sum of 3 quarters · filed 2017-02-15 | $3.32M 10-K · filed 2017-02-15 | ||||
| 2015-09-30 | $163.59K 10-Q · filed 2016-11-14 | $163.59K 10-Q · filed 2015-11-13 | $2.10M derived: sum of 2 quarters · filed 2016-11-14 | $3.03M 10-Q · filed 2016-11-14 | $3.21M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $1.94M 10-Q · filed 2016-08-15 | $2.87M 10-Q · filed 2016-08-15 | $3.05M derived: sum of 3 quarters · filed 2016-08-15 | $3.19M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $933.03K 10-Q · filed 2016-05-10 | $1.11M derived: sum of 2 quarters · filed 2016-05-10 | $1.26M derived: sum of 3 quarters · filed 2016-05-10 | $1.27M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | $176.95K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $325.17K derived: sum of 2 quarters · filed 2016-03-29 | $332.19K derived: sum of 3 quarters · filed 2016-03-29 | $345.34K 10-K · filed 2016-03-29 | ||||
| 2014-09-30 | $148.22K 10-Q · filed 2015-11-13 | $155.23K derived: sum of 2 quarters · filed 2015-11-13 | $168.38K 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | $7.01K 10-Q · filed 2015-08-13 | $20.16K 10-Q · filed 2015-08-13 | ||||||
| 2014-03-31 | $13.15K 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |